Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 903 Print this page  Email this page Small font size Default font size Increase font size
Year : 2019  |  Volume : 34  |  Issue : 4  |  Page : 271-277

Diagnostic accuracy of dual-time-point fluorodeoxyglucose-positron emission tomography/computed tomography in verification local recurrence in pancreatic cancer patients

1 Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University, Cairo, Egypt
2 Department of Radiology, Al-Azhar University, Cairo, Egypt

Correspondence Address:
Dr. Esraa El-Kholy
Department of Radiation Oncology and Nuclear Medicine, National Cancer Institute, Cairo University, Cairo
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijnm.IJNM_97_19

Rights and Permissions

Purpose: The aim of this study was to evaluate the accuracy of dual-time point in differentiating benign from malignant local recurrent lesions in pancreatic cancer. Patients and Methods: Thirty-four patients with pancreatic cancer (22 males and 12 females, mean age: 58.3 ± 10.3) who presented with soft-tissue lesions at the operative bed. Early whole-body positron emission tomography/computed tomography (PET/CT) and delayed imaging on the abdomen were performed. The maximum standardized uptake value (SUVmax) of the initial image (SUVmax E) and the delayed image (SUVmax D) were determined. A Retention Index (RI) was also calculated. These indices were correlated with histopathology and follow-up as reference criteria. Results: No significant statistical difference in SUVmaxE was found between benign and malignant lesions, while SUVmaxD and RI of the malignant lesions (mean 8.6 ± 2.7 and 35.8 ± 18.3, respectively) were significantly higher than those of benign ones (mean 3.3 ± 1.4 and-6.2 ± 15.2, respectively) (P < 0.005). With SUVmaxD 4.9, malignancy could be predicted with the highest sensitivity (95.8%) and accuracy (94.1%) between the whole parameters. The estimated negative and positive predictive values (PPVs) were 90.0% and 95.8%, respectively. A cutoff point 16 for RI showed higher specificity and PPV (100% and 100%, respectively). Forty-seven total (11 benign and 36 malignant) lesions were identified. Increased SUVmax is noted on delayed images in most of malignant lesions, except for two that maintained stationary. Conclusion: Dual-time-point 18F fluorodeoxyglucose-PET/CT seems to be a reliable additional method to differentiate between malignant and benign postoperative local soft-tissue lesions in patients with pancreatic cancer.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded189    
    Comments [Add]    
    Cited by others 1    

Recommend this journal